Diseases, Conditions, Syndromes

Sofosbuvir improves renal safety in patients with chronic hep C

(HealthDay)—Sofosbuvir-based treatment appears to guarantee renal safety for patients with chronic hepatitis C virus over one year of follow-up, according to a study published online May 7 in the Journal of Clinical Pharmacy ...

HIV & AIDS

Rapid, successful response to ART for many patients with HIV

(HealthDay)—Many HIV-infected patients have rapid and successful immune and virological response to antiretroviral therapy (ART), according to a study published online Sept. 27 in the Journal of Clinical Pharmacy and Therapeutics.

Diseases, Conditions, Syndromes

FDA approves technivie for hepatitis C

(HealthDay)—Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without cirrhosis ...

page 1 from 4